Oasis Extracellular Matrix - Biochemically-interactive dressing

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

Disponible des:

William A Cook Australia Pty Ltd

clase:

Class III

Fabricat per:

Cook Biotech Incorporated 1425 Innovation Place, West Lafayette, Indiana, 47906 United States Of America

Área terapéutica:

34083 - Biochemically-interactive dressing

indicaciones terapéuticas:

OASIS Extracellular Matrix is derived using a process that retains the natural composition of matrix molecules. It functions by binding to the receptors on the cells to activate cellular processes, such as replication and growth factor secretion. Oasis Extracellular Matrix is indicated for the management of wounds including: ? Partial and full-thickness wounds ? Pressure Ulcers ? Venous ulcers ? Chronic vascular ulcers ? Diabetic ulcers ? Second-degree burns ? Third-degree burns ? Trauma wounds (abrasions, lacerations, skin tears) ? Donor sites/grafts ? Draining wounds ? Surgical wounds (post-Mohs? surgery, post-laser surgery, podiatric, wound dehiscence)

Estat d'Autorització:

A

Data d'autorització:

2018-03-08